Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$96,431
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 97 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-12-08 MORGES WAYNE SVP, Reg. Affairs & Quality Grant or award · Stock options (right to buy) +167,096 167,096
2014-01-29 MORGES WAYNE SVP, Regulatory Affairs & Qual Grant or award · Stock Option (right to buy) +190,000 190,000
2010-05-06 MORGES WAYNE VP, Regulatory Affairs & Qual Grant or award · Stock Option (right to buy) +75,000 75,000
2010-01-21 MORGES WAYNE VP, Regulatory Affairs & Qual Shares withheld for taxes −2,559 $1.73 $4K 35,532

Page 1 of 1 · 4 trades